Cathie Wood's ARK Invest Sells Over 840,000 Shares of Seres Therapeutics

Investing

Published: August 31, 2021 8:35 am

One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood sold over 840,000 shares of Seres Therapeutics Inc. (NASDAQ: MCRB) shares on Monday, as the price of this ETF was up nearly 1% in Monday’s session. The fund is up significantly in the past year.

ARK Innovation ETF (NYSEARCA: ARKK) sold 846,468 shares of Seres Therapeutics. At Monday’s closing price, this would have valued this sale at roughly $5.2 million. This is only a small fraction of the total holdings. This ETF is up 35% over the past 52 weeks.

Here are all the ARK Invest sales on Monday:

Fund	Ticker	Name	Shares
ARKF	6060HK	ZHONGAN ONLINE P&C INSURANCE	981,100
ARKF	9923HK	YEAHKA	297,200
ARKG	PSTI	PLURISTEM THERAPEUTICS	10,518
ARKG	CLLS	CELLECTIS	7,300
ARKG	RHHBY	ROCHE	78,900
ARKK	MCRB	SERES THERAPEUTICS	846,468
ARKK	IOVA	IOVANCE BIOTHERAPEUTICS	71,749
ARKQ	ISRG	INTUITIVE SURGICAL	1,700
ARKQ	NXPI	NXP SEMICONDUCTORS	13,000
ARKQ	BABA	ALIBABA	15,089
ARKQ	GOOG	ALPHABET	4,808
ARKW	MELI	MERCADOLIBRE	4,500
ARKW	SE	SEA	34,049

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

24/7 Wall St.
Fast Money Hedge Funds Are Buying These 5 Red-Hot Stocks Now

It’s Your Money, Your Future—Own It (sponsor)

Retirement can be daunting, but it doesn’t need to be.

Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.